Erratum: Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling

A funding statement is missing from the opening footnote section in the article by Stout and colleagues (1), published in the March 1, 2020, issue of the Journal. There should have been a footnote for Dr. Nicholas A. Turner that read:

N.A.T. was funded by an Antibacterial Resistance Leadership Group fellowship from the National Institute of Allergy and Infectious Diseases (UM1 AI104681). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.